Distinct regulation of cytosolic phospholipase A2 phosphorylation, translocation, proteolysis and activation by tumour necrosis factor-receptor subtypes

被引:36
作者
Jupp, OJ
Vandenabeele, P
MacEwan, DJ [1 ]
机构
[1] Univ Aberdeen, Inst Med Sci, Dept Biomed Sci, Aberdeen AB25 2ZD, Scotland
[2] Univ Ghent, Mol Signalling & Cell Death Unit, Dept Mol Biomed Res, B-9000 Ghent, Belgium
关键词
apoptosis; cytokine receptor; phosphatase; protein kinase; signal transduction;
D O I
10.1042/BJ20030705
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The hormonally regulated Ca2+-dependent enzyme, cytosolic phospholipase A(2), (cPLA(2)) is activated by a range of inflammatory stimuli. Tumour necrosis factor-alpha (TNF) is one of the first known Stimuli for cPLA, but it is not known whether both TNF receptor subtypes are involved in activating the lipase. In the present study, we show for the first time that both type 1 55 kDa TNFR (TNFR1) and type 11 75 kDa TNFR (TNFR2) stimulate cPLA(2) enzyme, but with distinct signalling mechanisms. TNFR I activates mitogen-activated protein kinase (MAPK) and p38MAPK. TNFR1 then phosphorylates and activates cPLA(2) in a MAPK-dependent fashion. Furthermore, TNFR1 causes the translocation and caspase-dependent proteolysis of cPLA, as part of its activation profile. TNFR2, on the other hand, does not cause the phosphorylation of cPLA(2) as it does not activate MAPK or p38MAPK, but instead activates cPLA(2) by causing its translocation to plasma membrane and perinuclear subcellular regions. TNFR2 activation causes a delayed, slight increase in [Ca2+](i) of < 50 nM that may contribute towards the translocation and activation of cPLA(2). Therefore both TNF receptor subtypes play a role in cPLA(2) activation, but by means of separate signal-transduction pathways.
引用
收藏
页码:453 / 461
页数:9
相关论文
共 55 条
[1]  
Adam-Klages S, 1998, J IMMUNOL, V161, P5687
[2]   Fas-induced arachidonic acid release is mediated by Ca2+-independent phospholipase A2 but not cytosolic phospholipase A2 which undergoes proteolytic inactivation [J].
Atsumi, G ;
Tajima, M ;
Hadano, A ;
Nakatani, Y ;
Murakami, M ;
Kudo, I .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (22) :13870-13877
[3]   Tumor necrosis factor-α mediates both apoptotic cell death and cell proliferation in a human hematopoietic cell line dependent on mitotic activity and receptor subtype expression [J].
Baxter, GT ;
Kuo, RC ;
Jupp, OJ ;
Vandenabeele, P ;
MacEwan, DJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (14) :9539-9547
[4]   Identification of the phosphorylation sites of cytosolic phospholipase A2 in agonist-stimulated human platelets and HeLa cells [J].
Börsch-Haubold, AG ;
Bartoli, F ;
Asselin, J ;
Dudler, T ;
Kramer, RM ;
Apitz-Castro, R ;
Watson, SP ;
Gelb, MH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (08) :4449-4458
[5]   Phosphorylation and activation of cytosolic phospholipase A(2) by 38-kDa mitogen-activated protein kinase in collagen-stimulated human platelets [J].
BorschHaubold, AG ;
Kramer, RM ;
Watson, SP .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 245 (03) :751-759
[6]   CELL KILLING AND INDUCTION OF MANGANOUS SUPEROXIDE-DISMUTASE BY TUMOR-NECROSIS-FACTOR-ALPHA IS MEDIATED BY LIPOXYGENASE METABOLITES OF ARACHIDONIC-ACID [J].
CHANG, DJ ;
RINGOLD, GM ;
HELLER, RA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 188 (02) :538-546
[7]   A NOVEL ARACHIDONIC ACID-SELECTIVE CYTOSOLIC PLA2 CONTAINS A CA2+-DEPENDENT TRANSLOCATION DOMAIN WITH HOMOLOGY TO PKC AND GAP [J].
CLARK, JD ;
LIN, LL ;
KRIZ, RW ;
RAMESHA, CS ;
SULTZMAN, LA ;
LIN, AY ;
MILONA, N ;
KNOPF, JL .
CELL, 1991, 65 (06) :1043-1051
[8]   PURIFICATION OF A 110-KILODALTON CYTOSOLIC PHOSPHOLIPASE-A2 FROM THE HUMAN MONOCYTIC CELL-LINE U937 [J].
CLARK, JD ;
MILONA, N ;
KNOPF, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (19) :7708-7712
[9]  
De Valck D, 1998, J CELL BIOCHEM, V71, P392, DOI 10.1002/(SICI)1097-4644(19981201)71:3<392::AID-JCB8>3.3.CO
[10]  
2-E